Related Experiment Videos
Candidate genes for osteoporosis. Therapeutic implications.
1Program for Population Genetics, Harvard School of Public Health, Boston, Massachusetts, USA. xxu@hohp.harvard.edu
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|August 14, 2002
Summary
Osteoporosis is a bone disease with genetic links affecting bone density and fracture risk. Future genetic research promises better diagnostics and targeted osteoporosis treatments.
Area of Science:
- Genetics
- Bone Biology
- Metabolic Diseases
Background:
- Osteoporosis affects 10 million Americans, characterized by low bone mass and increased fracture risk.
- Genetic factors significantly contribute to osteoporosis development.
- Candidate genes involved in calcium homeostasis, hormonal function, cell regulation, cartilage metabolism, and lipoprotein metabolism are implicated.
Purpose of the Study:
- To review the genetic basis of osteoporosis.
- To explore candidate genes and chromosomal regions associated with bone mineral density.
- To discuss the role of genetic polymorphisms in drug response and future personalized medicine approaches.
Main Methods:
- Review of family and twin studies identifying genetic contributions.
- Analysis of genome-wide scans for genes influencing bone mineral density.
- Examination of DNA polymorphisms in genes like vitamin D receptor and estrogen receptor 1.
Main Results:
- Multiple categories of candidate genes influence osteoporosis.
- Specific chromosomal regions are linked to bone mineral density.
- Genetic variations impact osteoporosis drug efficacy.
Conclusions:
- Genetic research is crucial for understanding osteoporosis.
- Advances in genomics will enable personalized risk assessment and treatment.
- Future diagnostics and therapies for osteoporosis will be more targeted and effective.